Clinical Trials Directory

Trials / Completed

CompletedNCT05772078

Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis

Compliance Rate After Therapy of Peri-implantitis: Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated. Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions. Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.

Conditions

Interventions

TypeNameDescription
OTHERAssess compliance rate and demographicsRecords to evaluate attendance rate

Timeline

Start date
2023-07-01
Primary completion
2023-07-01
Completion
2023-10-30
First posted
2023-03-16
Last updated
2024-04-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05772078. Inclusion in this directory is not an endorsement.

Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis (NCT05772078) · Clinical Trials Directory